Copyright: © 2023 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Heart disease in young elite athletes having a history of COVID-19

Makarov LM1,2,3, Komolyatova VN1,2, Kiselyova II1, Besportochny DA1, Akopyan AG1, Dmitrieva AV1, Aksenova NV1
About authors

1 Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical Biological Agency, Moscow, Russia

2 Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia

3 Academy of Postgraduate Education, Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical Biological Agency, Moscow, Russia

Correspondence should be addressed: Leonid M. Makarov
Moskvorechye, 20, Moscow, 115409, Russia; ur.liam@vorakamdinoel.rd

About paper

Funding: the study was supported by grant № 37В/CSM FMBA Rossii/22 of 10.08.2022.

Author contribution: Makarov LM — study concept and design, manuscript writing, conclusions; Komolyatova VN — data analysis by statistical and mathematical methods, literature data acquisition; Kiselyova II — clinical assessment of athletes, literature data acquisition; Besportochny DA — instrumental assessment, working on graphics; Akopyan AG, Dmitrieva AV — instrumental assessment; Aksyonova NV — selection of populations for assessment.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Pirogov Russian National Research Medical University (protocol № 217 of 18 April 2022) and conducted in accordance with the framework legislation "On Protection of Public Health"; the informed consent to examination was submitted by all participants.

Received: 2023-07-27 Accepted: 2023-08-23 Published online: 2023-09-30
|
Fig. Algorithm and results of the three-phase assessment of underage elite athletes aged 14–17, who have had SARS-CoV-2 infection
Table 1. Cardiovascular system alterations in underage elite athletes having a history of SARS-CoV-2 revealed during the first-phase assessment (see Figure). AVB — atrioventricular block; BEM — bicycle ergometry; PVC — ventricular extrasystole; LVEDD — left ventricular end-diastolic diameter; QTc — QT interval corrected using Bazett's formula (QT/√RR)
Table 2. Results of third-phase assessment of athletes having a history of SARS-CoV-2 infection (contrast-enhanced heart MRI). AVB – atrioventricular block; HRC — heart rate variability; BEM — bicycle ergometry; VT — ventricular tachycardia; PVC — ventricular extrasystole; LVEDD — left ventricular end-diastolic diameter; MTWA — microvolt T wave alternans; MRI — magnetic resonance imaging; HRT — heart rate turbulence; EF — ejection fraction; HM — Holter monitoring